Richard D. Francis, President and CEO at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 20,025 shares at $31.67 ($634K) on 2026-03-05, disclosed to the SEC on 2026-03-09.
Open-market sale of $634k TEVA by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TEVA | SELL | 2026-03-05 | $28.7M | — | Filing → |
| TEVA | SELL | 2026-02-18 | $30.6M | — | Filing → |
| TEVA | SELL | 2025-03-06 | $751K | — | Filing → |